Literature DB >> 3257221

High [18F]FDG uptake in primary cerebral lymphoma: a PET study.

Y Kuwabara1, Y Ichiya, M Otsuka, Y Miyake, R Gunasekera, K Hasuo, K Masuda, I Takeshita, H Fukui.   

Abstract

Two cases of primary intracranial malignant lymphoma with high uptake of [18F]fluorodeoxyglucose [( 18F]FDG) are reported. Malignant lymphomas should be considered in the differential diagnosis of brain tumors with high [18F]FDG uptake in positron emission tomography studies.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3257221     DOI： 10.1097/00004728-198801000-00008

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN： 0363-8715            Impact factor:   1.826


  11 in total

Review 1.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

Review 2.  Positron emission tomography in patients with primary CNS lymphomas.

Authors:  U Roelcke; K L Leenders
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

Review 3.  Current molecular imaging of spinal tumors in clinical practice.

Authors:  Nora Sandu; Gabriele Pöpperl; Marie-Elisabeth Toubert; Toma Spiriev; Belachew Arasho; Mikael Orabi; Bernhard Schaller
Journal:  Mol Med       Date:  2011-01-03       Impact factor: 6.354

Review 4.  Artificial Intelligence in Lymphoma PET Imaging:: A Scoping Review (Current Trends and Future Directions).

Authors:  Navid Hasani; Sriram S Paravastu; Faraz Farhadi; Fereshteh Yousefirizi; Michael A Morris; Arman Rahmim; Mark Roschewski; Ronald M Summers; Babak Saboury
Journal:  PET Clin       Date:  2022-01

Review 5.  Primary central nervous system involvement of the so called 'peripheral T-cell lymphoma'. Report of a case and review of the literature.

Authors:  K Mineura; J Sawataishi; T Sasajima; M Kowada; A Sugawara; K Ebina
Journal:  J Neurooncol       Date:  1993-06       Impact factor: 4.130

6.  Effects of radiotherapy determined by 11C-methyl-L-methionine positron emission tomography in patients with primary cerebral malignant lymphoma.

Authors:  J Sawataishi; K Mineura; T Sasajima; M Kowada; A Sugawara; F Shishido
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

7.  Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings.

Authors:  J P Crowe; L P Adler; R R Shenk; J Sunshine
Journal:  Ann Surg Oncol       Date:  1994-03       Impact factor: 5.344

8.  Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma.

Authors:  Sofiane Maza; Ralph Buchert; Winfried Brenner; Dieter Ludwig Munz; Eckhard Thiel; Agnieszka Korfel; Philipp Kiewe
Journal:  Radiol Oncol       Date:  2013-05-21       Impact factor: 2.991

9.  Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma-a narrative review.

Authors:  Simone Krebs; Julia G Barasch; Robert J Young; Christian Grommes; Heiko Schöder
Journal:  Ann Lymphoma       Date:  2021-06-30

10.  Role of (18)F-fluorodeoxyglucose Positron Emission Tomography scan in differentiating enhancing brain tumors.

Authors:  Kajal Das; Bhagwant R Mittal; Rakesh K Vasistha; Paramjit Singh; Suresh N Mathuriya
Journal:  Indian J Nucl Med       Date:  2011-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.